Close

Beyond Air and Goetz Healthcare Partner to Commercialise LungFit PH in Asia-Pacific

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

CMS in US Launches WISeR Model to Enhance Original Medicare

The Centers for Medicare & Medicaid Services (CMS) is...

England GP IT Market Witnesses Shake-Up Unseen in 25 Years

England’s National Health Service, which is popularly known as...

Label Expansion In Alzheimers Gives GE HealthCare An Edge

The US Food and Drug Administration (FDA) has gone...

US Health Systems Accelerating AI Collaborations

US Health systems are speeding up their collaborations with...

Beyond Air has entered into an agreement with Goetz Healthcare to facilitate the commercialisation of its LungFit PH device in specific countries within the Asia-Pacific region.

According to the agreement, Goetz Healthcare will make a milestone payment to Beyond Air once the LungFit PH obtains CE mark certification in the European Union. This CE mark certification not only signifies compliance with European standards but also serves as a route for potential approval in specific Asia-Pacific nations.

Through this partnership, healthcare institutions in a diverse range of countries, including Australia, New Zealand, Thailand, Philippines, Taiwan, Hong Kong, Malaysia, Pakistan, Singapore, and Vietnam will have the opportunity to leverage the benefits of the LungFit PH device.

LungFit PH, a cylinder-free phasic flow generator and delivery system with FDA premarket approval, presents a transformative solution for healthcare facilities in multiple countries. This innovative device is compatible with ventilators and can efficiently generate nitric oxide (NO) from ambient air on demand, enabling precise delivery to the lungs with concentrations ranging from 1 ppm to 80 ppm.

In the hospital setting, LungFit PH holds the potential to replace cumbersome high-pressure NO cylinders, offering a range of significant advantages. These include a substantial reduction in inventory and storage requirements, enhanced safety through the elimination of NO2 purging procedures, and a host of other benefits.

Latest stories

Related stories

CMS in US Launches WISeR Model to Enhance Original Medicare

The Centers for Medicare & Medicaid Services (CMS) is...

England GP IT Market Witnesses Shake-Up Unseen in 25 Years

England’s National Health Service, which is popularly known as...

Label Expansion In Alzheimers Gives GE HealthCare An Edge

The US Food and Drug Administration (FDA) has gone...

US Health Systems Accelerating AI Collaborations

US Health systems are speeding up their collaborations with...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back